ESC Premium Access

Atrial fibrillation and venous thromboembolism. a Swedish nationwide registry study on 1358274 individuals.

Presentation

About the speaker

Doctor Bjorn Hornestam

Sahlgrenska Academy, Gothenburg (Sweden)
0 follower

9 more presentations in this session

Higher risk of dementia without oral anticoagulation in atrial fibrillation

Speaker: Associate Professor L. Friberg (Bromma, SE)

Thumbnail

Anticoagulant use and associated outcomes in patients with atrial fibrillation and advanced kidney disease

Speaker: Doctor P. Noseworthy (Rochester, US)

Thumbnail

Age and gender differences in stroke and bleeding risks in atrial fibrillation patients treated with non-vitamin K antagonist oral anticoagulants

Speaker: Doctor P. Noseworthy (Rochester, US)

Thumbnail

Similar long-term risk of thromboembolic events in postoperative atrial fibrillation following coronary artery bypass grafting and non-valvular atrial fibrillation: need for anticoagulation?

Speaker: Mr J. Butt (Copenhagen, DK)

Thumbnail

Incidence, predictors and prognosis of thrombus formation on device in patients with atrial fibrillation after left atrial appendage occlusion for stroke prevention in a multicenter analysis.

Speaker: Professor L. Fauchier (Tours, FR)

Thumbnail

Access the full session

Anticoagulation in atrial fibrillation

Speakers: Doctor B. Hornestam, Associate Professor L. Friberg, Doctor P. Noseworthy, Doctor P. Noseworthy, Mr J. Butt...
Thumbnail

About the event

Image

ESC CONGRESS 2017

26 August - 30 August 2017

Sessions Presentations

This platform is supported by

logo Novo Nordisk